Learning Activities

CDERLearn in the Center for Drug Evaluation and Research (CDER) offers a variety of learning opportunities for healthcare professionals, industry, consumers, and academia. The goal is to create a body of educational and information modules about human drug regulation and activities. CDERLearn is a way to share FDA expertise in specific subject areas to further instruct the public about the many ways CDER protects and promotes public health. CDERLearn

Sub-Topic Paragraphs

FDA Proposes Redesign of Human Foods Program to Enhance Coordinated Prevention and Response Activities

Jan 31

FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward

Jan 26

La FDA concluye que los marcos regulatorios existentes para alimentos y suplementos no son apropiados para el cannabidiol, trabajará con el Congreso en una nueva forma de proceder

Jan 26

Remarks by Commissioner Robert M. Califf, M.D. at the FDA-U.S. Patent and Trademark Office Public Workshop - 01/19/2023

Jan 19

FDA Provides Update on External Evaluation to Strengthen Agency’s Tobacco Program

Dec 19

Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting to Discuss Future Vaccination Regimens Addressing COVID-19

Dec 16

FDA Provides Update on External Evaluation to Strengthen Agency’s Human Foods Program

Dec 06

La FDA impulsa la innovación para los alimentos de consumo humano a partir de la tecnología de cultivo de células animales

Nov 16

Jan 31

IBSA Pharma Inc. Issues Voluntary Nationwide Recall of Select Lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution Due to Subpotency

Drugs

Jan 31

Certain Philips Respironics Masks for BiPAP, CPAP Machines Recalled Due to Safety Issue with Magnets That May Affect Certain Medical Devices: Letter to Health Care Providers

Medical Devices

Jan 31

Philips Respironics Recalls Certain Masks for BiPAP, CPAP Machines Due to Safety Issue with Magnets That May Affect Certain Medical Devices

More MedWatch Safety Alerts

U.S. Food and Drug Administration

Learning Activities

Latest From the Commissioner

FDA Proposes Redesign of Human Foods Program to Enhance Coordinated Prevention and Response Activities

FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward

La FDA concluye que los marcos regulatorios existentes para alimentos y suplementos no son apropiados para el cannabidiol, trabajará con el Congreso en una nueva forma de proceder

Remarks by Commissioner Robert M. Califf, M.D. at the FDA-U.S. Patent and Trademark Office Public Workshop - 01/19/2023

FDA Provides Update on External Evaluation to Strengthen Agency’s Tobacco Program

Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting to Discuss Future Vaccination Regimens Addressing COVID-19

FDA Provides Update on External Evaluation to Strengthen Agency’s Human Foods Program

La FDA impulsa la innovación para los alimentos de consumo humano a partir de la tecnología de cultivo de células animales

MedWatch Safety Alerts

IBSA Pharma Inc. Issues Voluntary Nationwide Recall of Select Lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution Due to Subpotency

Certain Philips Respironics Masks for BiPAP, CPAP Machines Recalled Due to Safety Issue with Magnets That May Affect Certain Medical Devices: Letter to Health Care Providers

Philips Respironics Recalls Certain Masks for BiPAP, CPAP Machines Due to Safety Issue with Magnets That May Affect Certain Medical Devices

FDA Proposes Redesign of Human Foods Program to Enhance Coordinated Prevention and Response Activities

FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward

La FDA concluye que los marcos regulatorios existentes para alimentos y suplementos no son apropiados para el cannabidiol, trabajará con el Congreso en una nueva forma de proceder

Remarks by Commissioner Robert M. Califf, M.D. at the FDA-U.S. Patent and Trademark Office Public Workshop - 01/19/2023

FDA Provides Update on External Evaluation to Strengthen Agency’s Tobacco Program

Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting to Discuss Future Vaccination Regimens Addressing COVID-19

FDA Provides Update on External Evaluation to Strengthen Agency’s Human Foods Program

La FDA impulsa la innovación para los alimentos de consumo humano a partir de la tecnología de cultivo de células animales

IBSA Pharma Inc. Issues Voluntary Nationwide Recall of Select Lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution Due to Subpotency

Certain Philips Respironics Masks for BiPAP, CPAP Machines Recalled Due to Safety Issue with Magnets That May Affect Certain Medical Devices: Letter to Health Care Providers

Philips Respironics Recalls Certain Masks for BiPAP, CPAP Machines Due to Safety Issue with Magnets That May Affect Certain Medical Devices

Stakeholder Update